Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ENTX stock hub

Entera Bio Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ENTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

60.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ENTX

In the news

Latest news · ENTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-82.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-50.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ENTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001638097
Company name	Entera Bio Ltd.
Country	Israel
Country code	US
Cusip	M40527109
Employees	22
Employees Change	2%
Employees Change Percent	10
Enterprise value	$56.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2018-06-28
Isin	IL0011429839
Last refreshed	2026-05-10
Market cap	$60.6M
Market cap category	Micro-Cap
Price	$1.3
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	ENTX
Website	https://enterabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-20.42%
FCF yield	-15.11%
P/B ratio	5.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-12.4M
Net Income Growth Years	0%
Profit Per Employee	$-562,591
ROA	-45.01
Roa5y	-48.78
ROCE	-108.2
ROE	-82.33
Roe5y	-89.77
ROIC	-50.86

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-40.39%
Cagr3y	16.59%
Cagr5y	-16.38%
EPS Growth Years	0
Revenue Growth	-76.8x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$13.1M
Cash	$4.1M
Current Assets	$12.5M
Current Liabilities	$1.6M
Debt	$448,000
Debt Equity	$0.04
Equity	$10.7M
Liabilities	$2.4M
Long Term Assets	$636,000
Long Term Liabilities	$866,000
Net Cash	$3.7M
Net Cash By Market Cap	$6.09
Net Cash Growth	-70.14%
Net Debt Equity	$-0.35
Tangible Book Value	$10.7M
Tangible Book Value Per Share	$0.23
WACC	12.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.93
Net Working Capital	$7M
Quick ratio	2.63
Working Capital	$10.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.29%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-40.37%
200-day SMA	1.8
3Y total return	58.52%
50-day SMA	1.21
50-day SMA vs 200-day SMA	50under200
5Y total return	-59.12%
All Time High	10.16
All Time High Change	-87.2%
All Time High Date	2021-03-12
All Time Low	0.47
All Time Low Change	175.31%
All Time Low Date	2022-11-11
ATR	0.12
Beta	1.55
Beta1y	-0.83
Beta2y	0.43
Ch YTD	-32.99
High	1.35
High52	3.22
High52 Date	2025-11-06
High52ch	-59.63%
Low	1.25
Low52	0.91
Low52 Date	2026-03-30
Low52ch	42.86%
Ma50ch	7.08%
Premarket Change Percent	-4.82
Premarket Price	$1.3
Premarket Volume	494
Price vs 200-day SMA	-27.74%
RSI	56.09
RSI Monthly	44.12
RSI Weekly	44.29
Sharpe ratio	-0.25x
Sortino ratio	-0.32
Total Return	-20.29%
Tr YTD	-32.99
Tr1m	11.11%
Tr1w	18.18%
Tr3m	25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.08
Operating Income	$-12.5M
Price target	$9
Price Target Change	$592

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32,236,877%
Float Percent	69.14%
Shares Insiders	2.33%
Shares Institutions	12.14%
Shares Out	46,622,239
Shares Qo Q	1.02%
Shares Yo Y	20.29%
Short Float	0.6%
Short Ratio	1.08
Short Shares	0.41

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12M
Average Volume	219,099.55x
Bv Per Share	0.23
CAPEX	$-99,000
Ch1m	11.11
Ch1w	18.18
Ch1y	-40.37
Ch3m	25
Ch3y	58.52
Ch5y	-59.12
Ch6m	-58.6
Change	-5.11%
Change From Open	-3.7
Close	1.37
Days Gap	-1.46
Depreciation Amortization	29,000
Dollar Volume	205,433.8
Earnings Date	2026-05-08
Earnings Time	amc
EBIT	$-12.5M
EBITDA	$-12.5M
EPS	$-0.26
F Score	1
FCF	$-9.2M
FCF EV Yield	-16.08x
FCF Per Share	$-0.2
Financing CF	503,000
Fiscal Year End	December
Founded	2,010
Investing CF	-99,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-27
Ma150	1.76
Ma150ch	-26.14%
Ma20	1.19
Ma20ch	9.06%
Net CF	-8,612,000
Next Earnings Date	2026-08-07
Open	1.35
Optionable	Yes
Position In Range	50
Post Close	1.3
Postmarket Change Percent	-0.77
Postmarket Price	$1.29
Ppne	540,000
Pre Close	1.37
Price Date	2026-05-08
Ptbv Ratio	5.67
Relative Volume	0.72x
Share Based Comp	2,818,000
Tr6m	-58.6%
Volume	158,026

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ENTX pay a dividend?

Capital-return profile for this ticker.

Performance

ENTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ENTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.1%

Float: +69.1% of shares outstanding

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ENTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.1

Neutral momentum band

Price vs 200-day MA

-27.7%

50/200-day relationship not available

Beta (5Y)

1.55

More volatile than the market

Sharpe ratio

-0.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ENTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ENTX stock rating?

Entera Bio Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ENTX analysis?

The full report lives at /stocks/ENTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ENTX?

The latest report frames ENTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ENTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.